Estimands in cluster-randomized trials: choosing analyses that answer the right question
International Journal of Epidemiology · 2023
DOI: 10.1093/ije/dyac131 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Epidemiology, 2023. Verfasst von Brennan C Kahan und 3 weiteren Autor:innen. Beteiligte Einrichtung: MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 119-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, Medical Research Council.
Abstract (Originalsprache)
Background
Cluster-randomized trials (CRTs) involve randomizing groups of individuals (e.g. hospitals, schools or villages) to different interventions. Various approaches exist for analysing CRTs but there has been little discussion around the treatment effects (estimands) targeted by each.
Methods
We describe the different estimands that can be addressed through CRTs and demonstrate how choices between different analytic approaches can impact the interpretation of results by fundamentally changing the question being asked, or, equivalently, the target estimand.
Results
CRTs can address either the participant-average treatment effect (the average treatment effect across participants) or the cluster-average treatment effect (the average treatment effect across clusters). These two estimands can differ when participant outcomes or the treatment effect depends on the cluster size (referred to as ‘informative cluster size’), which can occur for reasons such as differences in staffing levels or types of participants between small and large clusters. Furthermore, common estimators, such as mixed-effects models or generalized estimating equations with an exchangeable working correlation structure, can produce biased estimates for both the participant-average and cluster-average treatment effects when cluster size is informative. We describe alternative estimators (independence estimating equations and cluster-level analyses) that are unbiased for CRTs even when informative cluster size is present.
Conclusion
We conclude that careful specification of the estimand at the outset can ensure that the study question being addressed is clear and relevant, and, in turn, that the selected estimator provides an unbiased estimate of the desired quantity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, London, UK.
- Department of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
- Center for Methods in Implementation and Prevention Science, Yale University School of Public Health, New Haven, CT, USA.
- Clinical Trials Methods and Outcomes Lab, PAIR (Palliative and Advanced Illness Research) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
- Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
ORCID-Profile: Fan Li, Michael O Harhay
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- Medical Research Council
- MRC
- National Heart, Lung, and Blood Institute
- United States National Institutes of Health
- NIH
- Patient-Centered Outcomes Research Institute
Zitieren
APA
Kahan, B. C., Li, F., Copas, A. J., & Harhay, M. O. (2023). Estimands in cluster-randomized trials: choosing analyses that answer the right question. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyac131
Vancouver
Kahan BC, Li F, Copas AJ, Harhay MO. Estimands in cluster-randomized trials: choosing analyses that answer the right question. International Journal of Epidemiology. 2023. doi:10.1093/ije/dyac131
BibTeX
@article{Kahan2023,
author = {Kahan, Brennan C and Li, Fan and Copas, Andrew J and Harhay, Michael O},
title = {Estimands in cluster-randomized trials: choosing analyses that answer the right question},
journal = {International Journal of Epidemiology},
year = {2023},
doi = {10.1093/ije/dyac131}
}
EUVIMED